← Eichor
Study identifier: NCT06662084 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The ECMOCYP (cytochromes P450 Activity) Study

Condition: ECMO · Cardiogenic Shock · Temporary Mechanical Circulatory Support  ·  Sponsor: University Hospital, Geneva

PhaseN/A
Planned participants46
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective open label observational study including patients requiring a tMCS (VA-ECMO or Impella® CP) or in in cardiogenic shock according to the SCAI (Society for Cardiovascular Angiography and Interventions) ESC (European Society of Cardiology) definition 41,42 and not requiring or not eligible to tMCS (ECMO, Impella®, intra-aortic balloon pump) (control group).

This description comes directly from the study's public registry record.

Talk to the study team

Jean Terrier, Dr  ·  +41795530888  ·  jean.terrier@hug.ch

Anastasia Zaslavskaya, Dr  ·  +41795535729  ·  anastasia.zaslavskaya@hug.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Of GenevaGeneva, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06662084